APO 1.25 (Ramipril 1.25 mg)
Pill imprint APO 1.25 has been identified as Ramipril 1.25 mg.
Ramipril is used in the treatment of high blood pressure; diabetic kidney disease; left ventricular dysfunction; heart attack; heart failure and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 1.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for APO 1.25 (Ramipril 1.25 mg)
- 1.25 mg
- Yellow & White
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
ferric oxide yellow
More about ramipril
- Other brands: Altace
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...